TipRanks
Go Ultimate55% OFF

Molina Healthcare (MHG) Stock Price & Analysis

MHG Stock Chart & Stats

No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
N/A
Average Volume (3M)
N/A
Market Cap
CHF 8.82B
Enterprise Value
CHF 13.69B
Total Cash (Recent Filing)
CHF 8.58B
Total Debt (Recent Filing)
CHF 3.95B
Price to Earnings (P/E)
―
Beta
0.90
Next Earnings
Feb 10, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Improving Medicaid Rate Setup

Expected Medicaid rates broadly covering medical cost trend could stabilize the segment’s economics after several years of pressure. If achieved, this supports more predictable margins, improves earnings resilience, and creates an opportunity for gradual profitability improvement across the core business.

Florida CMS Contract Expansion

The successful launch of a large contract expands Molina’s membership and revenue base while demonstrating operational execution on a material program. Management’s expectation of break-even next year and the full target margin in year two could make this a durable earnings contributor.

Large Contract Pipeline

A substantial pipeline of government contract opportunities gives Molina multiple avenues to extend enrollment and premium growth beyond its existing book. Winning selected awards would reinforce scale, deepen state relationships, and support longer-term operating leverage in the managed-care platform.

Bears Say

Weakened Profitability And Cash Generation

The recent shift from healthy prior-year profitability to a TTM loss reduces earnings resilience and makes internal funding less dependable. Negative 2025 operating and free cash flow also indicate that medical-cost or claims-related pressure can materially affect liquidity and constrain investment flexibility.

Persistent Medicaid Membership Attrition

Sustained Medicaid membership declines can reduce premium volume and dilute the benefits of Molina’s fixed operating infrastructure. Although acuity may shift upward, repeated attrition raises execution demands, complicates capacity planning, and makes durable revenue growth more dependent on new contract wins.

Delayed Georgia And Texas Contracts

Delays to major Medicaid awards defer expected premium growth and postpone the operating leverage associated with higher enrollment. Judicial proceedings also extend timing uncertainty, while the lower near-term revenue base can reduce the pace at which Molina realizes its planned embedded earnings.

Molina Healthcare News

MHG FAQ

What is Molina Healthcare’s market cap?
Molina Healthcare’s market cap is CHF8.82B.
When is Molina Healthcare’s upcoming earnings report date?
Molina Healthcare’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 100 days.
How were Molina Healthcare’s earnings last quarter?
Molina Healthcare released its earnings results on Oct 21, 2026. The company reported CHF0.734 earnings per share for the quarter, beating the consensus estimate of CHF0.652 by CHF0.082.
Is Molina Healthcare overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Molina Healthcare pay dividends?
Molina Healthcare does not currently pay dividends.
What is Molina Healthcare’s EPS estimate?
Molina Healthcare’s EPS estimate is 0.43.
How many shares outstanding does Molina Healthcare have?
Molina Healthcare has 52,200,000 shares outstanding.
What happened to Molina Healthcare’s price movement after its last earnings report?
Molina Healthcare reported an EPS of CHF0.734 in its last earnings report, beating expectations of CHF0.652. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Molina Healthcare?
Hedge funds hold Molina Healthcare shares: the largest hedge-fund position in Molina Healthcare is 817,893,002 shares, and hedge funds decreased their holdings by 708.6K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology